NCT04427774 2021-07-20A Study of Surufatinib Plus Sintilimab in Patients With Advanced Solid TumorInnovent Biologics (Suzhou) Co. Ltd.Phase 1 Terminated8 enrolled
NCT03879057 2019-10-01Trial of Surufatinib Combined With JS001 in the Treatment of Advanced Solid TumorsPeking UniversityPhase 1 Unknown24 enrolled